FDA approves combination Yuvezzi eye drop for presbyopia in adults

The U.S. Food and Drug Administration has approved Yuvezzi (carbachol and brimonidine tartrate) ophthalmic solution 2.75%/0.1 ...

Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI(TM), the First and Only Combination Eye Drop Approved to Treat Presbyopia

YUVEZZI (TM) (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is a dual-agent eye drop approved by the U.S. Food & Drug Administration (FDA) for the treatment of presbyopia, a ...
Dealbreaker on MSN

Presbyopia eye drop from startup Tenpoint gets FDA approval, paving way for $235M financing

Tenpoint Therapeutics’ Yuvezzi brings a combination approach to presbyopia compared to single mechanisms of action offered by once-daily eye drops from Orasis Pharmaceuticals, Lenz Therapeutics, and ...
InvisionMag

Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI

YUVEZZITM: the first and only combination eye drop approved to treat presbyopia.